
912.74MUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US50127T1097
CUSIP
50127T109
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.54
Dividend Share
-
Dividend Yield
-
Earnings Share
-3.37
Wall Street Target Price
31.85
EPS Estimate Current Year
-3.17
EPS Estimate Next Year
-2.34
EPS Estimate Current Quarter
-0.8756
EPS Estimate Next Quarter
-0.8922
Most Recent Quarter
-
Revenue TTM
77,225,000
Gross Profit TTM
-182,807,008
EBITDA
-316,799,008
Profit Margin
0.00%
Return On Assets TTM
-31.30%
Return On Equity TTM
-167.71%
Revenue Per Share TTM
0.875
Qtly Revenue Growth YOY
36.50%
Diluted Eps TTM
-3.37
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
11.8192
Price Book MRQ
18.8645
Enterprise Value Revenue
5
Enterprise Value EBITDA
-2
903.08
3.20%227.40
2.97%965.00
0.55%314.92
0.35%900.30
0.00%139.16
0.00%528.21
-4.77%355.10
-2.26%34.64
-2.01%153.70
-1.47%